Advertisement

Topics

Merck Keeps Edge Over Bristol-Myers In Cancer Duel

05:30 EDT 16 Apr 2018 | Forbes

Another study combined Opdivo and Yervoy, two drugs made by Bristol-Myers Squibb, in lung cancer patients selected with a new type of diagnostic test. An third result hints that giving Opdivo earlier – before surgery to remove tumors – may lead to even more benefits for patients.

Original Article: Merck Keeps Edge Over Bristol-Myers In Cancer Duel

NEXT ARTICLE

More From BioPortfolio on "Merck Keeps Edge Over Bristol-Myers In Cancer Duel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...